新雷能：股东上海联芯投资管理合伙企业（有限合伙）拟减持不超过350万股

Group 1 - The core point of the article is that Shanghai Lianxin Investment Management Partnership plans to reduce its holdings in Newrayon by up to 3.5 million shares, which represents 0.65% of the total share capital after excluding shares in the repurchase account [1] - The reduction will occur through centralized bidding and block trading within a three-month period starting from November 13, 2025, to February 12, 2026 [1] - The shareholder currently holds approximately 6.01 million shares, accounting for 1.11% of the total share capital after excluding shares in the repurchase account [1] Group 2 - The article also mentions issues faced by Nohui Health, including empty office spaces at its Hangzhou headquarters and overdue rent payments at its Beijing laboratory [1] - Former employees suggest that the reported issues are just the tip of the iceberg, indicating deeper problems within the company [1]